Gene Patent Ruling Fuels US Court Protest to Stem Cell Rights – Businessweek
|
Gene Patent Ruling Fuels US Court Protest to Stem Cell Rights
Businessweek As scientists get closer to using embryonic stem cells in new treatments for blindness, spinal cord injuries and heart disease, a U.S. legal debate could determine who profits from that research. Consumer Watchdog, a nonprofit advocacy group, wants an … |
